Figure S5 from AKT1^E17K Activates Focal Adhesion Kinase and Promotes Melanoma Brain Metastasis

Supplementary Figure 5. Tumors cluster based on gene expression profile.</p

Supplementary Data from AKT1^E17K Activates Focal Adhesion Kinase and Promotes Melanoma Brain Metastasis

Supplementary Materials and Methods</p

Figure S1 from AKT1^E17K Activates Focal Adhesion Kinase and Promotes Melanoma Brain Metastasis

Supplementary Figure 1. RCAS mutant AKT viruses infect TVA+ melanoma cells.</p

Figure S4 from AKT1^E17K Activates Focal Adhesion Kinase and Promotes Melanoma Brain Metastasis

Supplementary Figure 4. P-FAK and P-paxillin are elevated in tumors that express AKT1E17K.</p

Supplementary Figures from The Glutaminase Inhibitor CB-839 (Telaglenastat) Enhances the Antimelanoma Activity of T-Cell–Mediated Immunotherapies

Supplementary figures</p

Supplementary Methods from The Glutaminase Inhibitor CB-839 (Telaglenastat) Enhances the Antimelanoma Activity of T-Cell–Mediated Immunotherapies

Supplementary Methods</p

Figure S2 from AKT1^E17K Activates Focal Adhesion Kinase and Promotes Melanoma Brain Metastasis

Supplementary Figure 2. Kinase-dead AKT1E17K (AKT1E17K, K179M) and wild type AKT1 expressing melanomas do not impact survival compared with Cre-only controls (BRAFV600E;Cdkn2a-/-;Pten-/-).</p

Figure S6 from AKT1^E17K Activates Focal Adhesion Kinase and Promotes Melanoma Brain Metastasis

Supplementary Figure 6. Expression of AKT1E17K promotes the dysregulation of integrins.</p

Figure S7 from AKT1^E17K Activates Focal Adhesion Kinase and Promotes Melanoma Brain Metastasis

Supplementary Figure 7. AKT1E17K does not promote cell proliferation compared with controls.</p

Table S1 from AKT1^E17K Activates Focal Adhesion Kinase and Promotes Melanoma Brain Metastasis

Supplementary Table 1. Summary of tumor formation in Dct::TVA mice. .</p